Drug Type Small molecule drug |
Synonyms SP-8232 |
Target |
Action inhibitors |
Mechanism GRK5 inhibitors(G protein-coupled receptor kinase 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Heart Failure | Preclinical | South Korea | 30 Jan 2022 |





